2008•Chinese HepatologyRequires access

Moleculer mechanisms of cholestyramine in promoting bile acid synthesis

Qiqi Mao

Open publisher page 0 citations

Abstract

Objective To study the possible mechanisms of cholestyramine promoting bile acid synthesis in vitro.Methods Twenty New Zealand white rabbits were divided into cholestyramine group (n=10) and control group (n=10). Each rabbit in treatment group was administered with cholestyramine 1 g/kg per day for 2 weeks by gavage. The serum bile acids level, serum cholesterol level and activity and mRNA expression of cholesterol 7-alpha-dydroxylase (CYP7A1) in liver tissues after treatment were assessed. The mRNA expression of farnesoid X receptor (FXR) target genes, short heterodimer partner (SHP) and bile salt export pump (BSEP) in liver tissues, and the mRNA expression of LDL-R in liver tissues were also detected. Results The serum cholesterol level decreased 10.25% in cholestyramine group, while the serum bile acids level had no changes. In the liver tissues, the activity and mRNA expression of CYP7A1 significantly increased (P0.05), the mRNA expression of FXR target gene SHP and BESP significantly decreased (P0.01),and the mRNA expression of LDL-R significantly increased (P0.05)as compared with those in the controls.Conclusion Cholestyramine can decrease the reAbsorption of bile acid (the ligand of FXR) to the liver where inactivates FXR, and activates CYP7A1 and promotes the synthesis of bile acid, then maintains the bile acid level and lowers serum cholesterol.

About this research paper

What this paper is about

Objective To study the possible mechanisms of cholestyramine promoting bile acid synthesis in vitro.Methods Twenty New Zealand white rabbits were divided into cholestyramine group (n=10) and control group (n=10). Each rabbit in treatment group was administered with cholestyramine 1 g/kg per day for 2 weeks by gavage. The serum bile acids level, serum cholesterol level and activity and mRNA expression of cholesterol 7-alpha-dydroxylase (CYP7A1) in liver tissues after treatment were assessed. The mRNA expression of farnesoid X receptor (FXR) target genes, short heterodimer partner (SHP) and bile salt export pump (BSEP) in liver tissues, and the mRNA expression of LDL-R in liver tissues were also detected. Results The serum cholesterol level decreased 10.25% in cholestyramine group, while the serum bile acids level had no changes. In the liver tissues, the activity and mRNA expression of CYP7A1 significantly increased (P0.05), the mRNA expression of FXR target gene SHP and BESP significantly decreased (P0.01),and the mRNA expression of LDL-R significantly increased (P0.05)as compared with those in the controls.Conclusion Cholestyramine can decrease the reAbsorption of bile acid (the ligand of FXR) to the liver where inactivates FXR, and activates CYP7A1 and promotes the synthesis of bile acid, then maintains the bile acid level and lowers serum cholesterol.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To study the possible mechanisms of cholestyramine promoting bile acid synthesis in vitro.Methods Twenty New Zealand white rabbits were divided into cholestyramine group (n=10) and control group (n=10). Each rabbit in treatment group was administered with cholestyramine 1 g/kg per day for 2 weeks by gavage. The serum bile acids level, serum cholesterol level and activity and mRNA expression of cholesterol 7-alpha-dydroxylase (CYP7A1) in liver tissues after treatment were assessed. The mRNA expression of farnesoid X receptor (FXR) target genes, short heterodimer partner (SHP) and bile salt export pump (BSEP) in liver tissues, and the mRNA expression of LDL-R in liver tissues were also detected. Results The serum cholesterol level decreased 10.25% in cholestyramine group, while the serum bile acids level had no changes. In the liver tissues, the activity and mRNA expression of CYP7A1 significantly increased (P0.05), the mRNA expression of FXR target gene SHP and BESP significantly decreased (P0.01),and the mRNA expression of LDL-R significantly increased (P0.05)as compared with those in the controls.Conclusion Cholestyramine can decrease the reAbsorption of bile acid (the ligand of FXR) to the liver where inactivates FXR, and activates CYP7A1 and promotes the synthesis of bile acid, then maintains the bile acid level and lowers serum cholesterol.

Key concepts: Cholestyramine, Cholesterol 7 alpha-hydroxylase, Farnesoid X receptor, Bile acid, Internal medicine, Endocrinology, Cholesterol, CYP8B1

Related papers

Back to paper searchBrowse research topicsOriginal source
Moleculer mechanisms of cholestyramine in promoting bile acid synthesis — Research Paper | ScholarLens